SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-24-000021
Filing Date
2024-05-08
Accepted
2024-05-08 16:46:14
Documents
102
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20240331.htm   iXBRL 10-Q 1393007
2 EX-31.1 amrx-2024033110xqexx311.htm EX-31.1 10347
3 EX-31.2 amrx-2024033110xqexx312.htm EX-31.2 10264
4 EX-31.3 amrx-2024033110xqexx313.htm EX-31.3 10421
5 EX-32.1 amrx-2024033110xqexx321.htm EX-32.1 5617
6 EX-32.2 amrx-2024033110xqexx322.htm EX-32.2 5563
7 EX-32.3 amrx-2024033110xqexx323.htm EX-32.3 5651
  Complete submission text file 0001723128-24-000021.txt   8724432

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20240331.xsd EX-101.SCH 82168
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20240331_cal.xml EX-101.CAL 90909
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20240331_def.xml EX-101.DEF 355779
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20240331_lab.xml EX-101.LAB 715799
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20240331_pre.xml EX-101.PRE 521984
105 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20240331_htm.xml XML 1357771
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 24927030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)